Related Experiment Video

Updated: Jun 12, 2026

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo
05:14

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo

Published on: May 16, 2020

Risk stratification in nonischemic dilated cardiomyopathy: Current perspectives

Sercan Okutucu1, Ali Oto

  • 1Department of Cardiology, Hacettepe University Faculty of Medicine, Ankara, Turkey.

Cardiology Journal
|June 11, 2010
PubMed

Insights

Identifying high-risk patients with nonischemic dilated cardiomyopathy is crucial for reducing sudden cardiac death. This review summarizes current risk stratification methods for this condition.

Area of Science:

  • Cardiology
  • Electrophysiology
  • Heart Failure Research

Background:

  • Sudden cardiac death (SCD) risk stratification aims to identify high-risk individuals for targeted intervention.
  • While extensively studied post-myocardial infarction, risk stratification in nonischemic dilated cardiomyopathy (NIDCM) remains less defined.
  • Effective risk assessment in NIDCM is critical for preventing sudden death.

Purpose of the Study:

  • To review and summarize current diagnostic methods for risk stratification of sudden cardiac death in NIDCM.
  • To discuss the clinical implications of these risk stratification techniques in managing NIDCM patients.

Main Methods:

  • Comprehensive literature review of diagnostic modalities used for NIDCM risk stratification.
  • Analysis of data concerning syncope, ECG parameters (QRS duration, QT dispersion/dynamicity), electrophysiological testing, heart rate variability, and cardiac MRI.
  • Synthesis of findings related to exercise and recovery parameters.

Main Results:

  • Multiple diagnostic tools exist for NIDCM risk stratification, including electrophysiological studies, ECG-derived markers, and advanced imaging.
  • Parameters like QRS duration, syncope, and specific ECG findings show prognostic value.
  • Cardiac magnetic resonance imaging offers structural and functional insights for risk assessment.

Conclusions:

  • A multi-faceted approach integrating various diagnostic tools is likely necessary for accurate SCD risk stratification in NIDCM.
  • Further research is needed to refine and validate these methods for clinical practice.
  • Improved risk stratification can guide therapeutic strategies and potentially reduce sudden cardiac death incidence in NIDCM.

More Related Videos

Echocardiographic Approaches and Protocols for Comprehensive Phenotypic Characterization of Valvular Heart Disease in Mice12:12

Echocardiographic Approaches and Protocols for Comprehensive Phenotypic Characterization of Valvular Heart Disease in Mice

Published on: February 14, 2017

Related Concept Videos

Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...